RVRevvity RVTY · NYSE
$150.85 -1.17% (-$1.79)
- Market cap
- $17.0B
- Enterprise value
- $19.3B
- P/E
- 71.7x
- Forward P/E
- 26.2x
- PEG
- -
- P/S
- 5.8x
- P/FCF
- 30.4x
- EV/EBITDA
- 25.2x
- ROIC
- 2.9%
- Gross margin
- 52.1%
- Net margin
- 8.2%
- Dividend yield
- 0.18%
- Payout ratio
- 13.2%
- Net debt/EBITDA
- 3.0x
- Beta
- 1.06
- Free float
- 91.9%
About the company
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Prahlad R. Singh
Employees
11,000
Headquarters
Waltham
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number